BTVCF yields 2.26% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, BTVCF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BTVCF + JNJ for your $10,000?
Britvic plc, together with its subsidiaries, manufactures, markets, distributes, and sells soft drinks in the United Kingdom, the Republic of Ireland, France, Brazil, and internationally. It also provides fruit juices, syrups, squash, mineral water, liquid concentrates, ready-to-drink nectar drinks, sodas, mixers, and energy and flavored drinks. The company offers its products under the 7UP, Aqua Libra, Ballygowan, Britvic, drench, Robinsons, Gatorade, J2O, Lipton, London Essence, Mathieu Teisseire, Mountain Dew, Pepsi MAX, Plenish, Purdey's, Rockstar, R. White's, Tango, Teisseire, Bela Ischia, Britvic, Dafruta, Maguary, Mathieu Teisseire, Pressade, Puro Coco, C&C, Cidona, Club, Edge, Energise Sport, MiWadi, Moulin de Valdonne, and TK brands. In addition, it supplies water-coolers and bottled water; engages in the wholesale of soft drinks to the licensed trade; offers pension funding and financing services; and designs, installs, and maintains integrated tap solutions. The company was incorporated in 2005 and is headquartered in Hemel Hempstead, the United Kingdom.
Full BTVCF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.